High Vista Strategies LLC Horizon Therapeutics Public LTD CO Transaction History

High Vista Strategies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $573,608 - $669,110	5,954 Added 20.53%	34,954 $3.6 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $3.11 Million - $3.29 Million	29,000 New	29,000 $3.17 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $332,073 - $477,200	5,636 Added 75.97%	13,055 $808,000
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $66,457 - $97,393	-837 Reduced 10.14%	7,419 $592,000
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $262,889 - $334,042	-3,042 Reduced 26.93%	8,256 $869,000

Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $240,712 - $289,059	2,619 Added 30.18%	11,298 $1.24 Million
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $7,847 - $8,728	91 Added 1.06%	8,679 $813,000
Q1 2021 May 17, 2021	BUY	$71.83 - $95.48 $616,876 - $819,982	8,588 New	8,588 $790,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.